Research: 3D device management surgical ophthalmology
PROFESSIONAL EXPERIENCE
nurse at public healthcare companies in the following fields:
oncology, cardiac surgery, cardiology emergency, Unit Therpy Coronaric (UTIC) from 1988 to 2008
nursing coordinator in the UTIC, COVID intensive care, ophthalmology at the ophthalmology operating block from 2008 to today;
nursing coordinatore in Emergency and Assistance Department (DEA ),Unit Therapy Coronaric (UTIC) at the Head and Neck Complex Area Department
TEACHING IN HEALTH CONVENTION
teaching in nursing sciences in the following fields: pediatrics, critical care, operating room, territorial and forensic assistance in the Nursing Science Course and Specialist Masters (critical care, nursing care in the operating room and PICC (Peripherally Inserted Central Catheter) and Medine Healthcare management) from 2011 to date Tutor in nursing laboratories from 2016 to date
Introductory lesson to the course for orthoptists (operating block courses) 2022
EDUCATION AND TRAINING
Nursing specialization course for assistance in anesthesia and resuscitation and intensive care achieved at the “Paolo Nazzaro” School for Professional Nursing on 06/28/1990 Romewifery; equivalent to the Master's degree in nursing coordination
Cardiocirculatory pathophysiology technician diploma (surgical address) obtained from the "La Sapienza" University of Rome on 11/25/1993;
Qualification for managerial functions obtained at the School for Professional Nursing "Suore della Misericordia" on 07/14/1995; equivalent to the Master in Critical Area
Master's degree in Nursing and Midwifery at the University of Rome "La Sapienza" at the II Faculty of Medicine and Surgery (S'Andrea Hospital) achieved on 05/27/2011 with honors
Master's degree in Forensic Nursing achieved on 05/17/2017 at UNITELMA SAPIENZA in Rome (1st level Master's degree)
Level II Master in Management and Management of Healthcare Companies at LUM University of Bari achieved on 02/17/2021
Enrollment in the IV degree of the Master's Degree Course in Law at Unitelma Sapienza from 03/19/2021
Technical Consultant Office at the Criminal Court of Rome Piazzale Clodio as a forensic nurse
PROFESSIONAL UPDATE
Partecipation in over 200 days as a student in good standing with ECM Continuing Medical Education
Parteicipation in over 20 events as speaker, moderator and scientific director
COLLABORATIONS AND PUBLICATIONS
“ROLE OF TOTAL BODY SCAN WITH 111 IN-OCTREOTIDE IN THE EVALUATION OF PATIENTS WITH LUNG CANCER: DIAGNOSTIC AND THERAPEUTIC IMPLICATIONS”, published in the Journal of Chemotherapy Vol:8 Supplement n.4 1996. The undersigned in the ASKNOWLEDGMENT;
“ROLE OF SURGERY IN THE TREATMENT OF RECURRENT ESOPHAGEAL CANCER” published in HEPATO-GASTROENTEROLOGY 44 (1997). The undersigned in the ASKNOWLEDGments
“ACCEPTANCE AND PREPARATION OF THE PATIENT IN OUTPATIENT SURGERY AND DAY SURGERY” published in “ONE DAY SURGERY AND OUTPATIENT SURGERY” IPASVI Arcobaleno series n.4 March 1997;
“NURSING, RESPIRATORY TRAINING AND REHABILITATION OF PATIENTS UNDERGOING LUNG AND THORACIC SURGERY” published in the Journal of Experimental & Clinical Cancer Research Supplement vol:16 N.2 June 1997
“PERITONECTOMY SURGERY: MULTI-DISCIPLINARY ASPECTS OF CARE” published in “The Nurse and modern surgery. The stoma patient: from basic management to integrated multidisciplinary care" Arcobaleno series IPASVI.n.9 April 1999.
Project Co-Investigator: 'A 4-week, Phase III, multicenter, double-blind, vehicle-controlled clinical study to evaluate the safety and efficacy of Oxervate® (cenegermin) ophthalmic solution 20 mcg/mL compared to vehicle, in patients with severe Sjogren's dry eye disease (PROTEGO-1 study). EUDRACT: 2021-003346-21. Sponsored by Dompé farmaceutici S.p.A. Principal Investigator (PI): Prof. Antonietta Moramarco
Project Co-Investigator: 'A 4-week, Phase III, multicenter, double-blind, vehicle-controlled clinical study to evaluate the safety and efficacy of Cenegermin (Oxervate®) 20 mcg/mL ophthalmic solution compared to vehicle , in patients with severe Sjogren's dry eye disease treated with ciclosporin A (PROTEGO-2 study)'. EUDRACT: 2021-003749-39. Sponsored by Dompé farmaceutici S.p.A. Principal Investigator (PI): Prof. Antonietta Moramarco